FOXO TECHNOLOGIES INC.
FOXODrugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
1 upcoming, 0 past
Acquisition — Grifols Bio Supplies, Inc.
FOXO Technologies' subsidiary Vector Biosource has entered into a definitive agreement to acquire four blood collection centers from Grifols Bio Supplies, Inc. Financial terms and closing conditions were not disclosed in the announcement.
No drugs found in this phase.
Full breakdown — the signals behind the verdict
Frequently asked questions
When is FOXO TECHNOLOGIES INC.'s next FDA catalyst?→
FOXO TECHNOLOGIES INC.'s (FOXO) next tracked catalyst is a Acquisition expected July 31, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track FOXO biotech catalysts?→
Add FOXO to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow FOXO TECHNOLOGIES INC.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.